Table 2 Relationship between PSMC2 expression and tumor characteristics in patients with ovarian cancer.
Features | No. of patients | PSMC2 expression | P value | |
|---|---|---|---|---|
Low | High | |||
All patients | 148 | 56 | 92 | |
Age (years) | 0.197 | |||
<52 | 74 | 32 | 42 | |
≥52 | 73 | 24 | 49 | |
Grade | 0.019* | |||
I | 14 | 6 | 8 | |
II | 17 | 10 | 7 | |
III | 86 | 23 | 63 | |
T Infiltrate | 0.715 | |||
T1 | 9 | 5 | 4 | |
T2 | 35 | 12 | 23 | |
T3 | 103 | 38 | 65 | |
Lymphatic metastasis (N) | 0.897 | |||
N0 | 106 | 40 | 66 | |
N1 | 41 | 15 | 26 | |
Metastasize (M) | 0.790 | |||
M0 | 114 | 42 | 72 | |
M1 | 33 | 13 | 20 | |
Stage | 0.896 | |||
1 | 9 | 5 | 4 | |
2 | 35 | 12 | 23 | |
3 | 70 | 25 | 45 | |
4 | 33 | 13 | 20 | |
Tumor size | 0.118 | |||
<12.5 cm | 73 | 23 | 50 | |
≥12.5 cm | 75 | 33 | 42 | |
Tumor recurrence | 0.359 | |||
No | 29 | 13 | 16 | |
Yes | 118 | 42 | 76 | |